Menopause represents an inevitable transition in a woman’s life, presenting with vasomotor symptoms, mood disorders, sleep difficulties, and prolonged risks such as osteoporosis and cardiovascular diseases. Hormone replacement therapy emerged as the cornerstone of menopausal management, particularly for alleviating symptoms and preventing postmenopausal osteoporosis. However, findings from the Women’s Health Initiative (WHI) study in 2002 highlighted increased risks of breast cancer, cardiovascular disease, and stroke associated with hormonal replacement treatment, leading to a significant global decline in its usage. Consequently, numerous women were deprived of essential therapy, endangering their health and quality of life. This review presents the findings of the WHI study, discusses its methodological errors, and evaluates its benefits and harms. We explore landmark studies that have reestablished the benefits and risks of hormone replacement therapy over the past two decades. Guidelines supported by these findings are presented in this review. Despite advancements, public perception of hormone replacement treatment remains influenced by outdated findings, limiting its utilization in many regions, especially in developing countries. Our objective is to provide evidence that misconceptions about hormone replacement therapy significantly impact women’s general health and quality of life, as well as to clarify the short-term and long-term impacts of hormone replacement therapy. We conclude that hormonal replacement treatment is effective and safe when administered according to established guidelines. Access to information, coupled with knowledgeable physicians who consistently interact with women, is as vital as the contributions of menopause healthcare specialists. Conflicting information from outdated professionals can likely lead to treatment failure in patients. Keywords: menopause, women’s health, estrogens, progestins, quality of life

This paper’s primary aim is to examine the impact of managerialcompetencies on the performance of healthcareorganizations in Bosnia and Herzegovina, with a particularfocus on the role of middle management.Research Methodology: A quantitative research approachwas employed, and data were collected through a structuredquestionnaire designed to measure six key dimensionsof managerial competencies: leadership, strategicthinking, communication, decision-making, teamwork, andchange management. The construction of the questionnairewas based on previous relevant research and theoretical models of managerial competencies, with particularattention given to the models developed by Boyatzis (1982)and later expanded by Whetten and Cameron (2011), as wellas findings from research on healthcare management, suchas Calhoun et al. (2008) on competencies for healthcareleaders. The items were adapted to the specific context ofhealthcare institutions in Bosnia and Herzegovina, and eachitem was rated on a 5-point Likert scale (1- Strongly Disagree;2-Disagree; 3 – Neutral; 4- Agree; 5- Strongly Agree).The questionnaire was distributed to a purposive sample of120 middle managers working in various healthcare institutionsacross Bosnia and Herzegovina. Data were collectedduring three months from January to April 2025. Descriptivestatistics were used for data analysis.Conclusion: The results indicate that communication andteamwork competencies were rated most positively and significantlycorrelated with organizational outcomes. In contrast,strategic thinking and change management receivedlower ratings. The instrument’s reliability was confirmedthrough high internal consistency (Cronbach α > 0.70).

Background: Assessment of the fetal nervous system - both in its anatomical structure and functional behaviour - has long been a challenge in perinatal medicine. Recent advances in ultrasound technology, especially 3D and 4D ultrasound, now allow detailed real-time observation of fetal anatomy and behavior. The development and maturation of the fetal brain in utero (and its continuity into extrauterine life) is a complex dynamic process: fetal neurobehavior is thought to follow a reproducible, gestational-age–dependent pattern that reflects neurological integrity. If normative fetal neurodevelopmental stages could be recognized and standardized, then deviations - abnormal neurobehaviors - could be identified, enabling prompt prenatal diagnosis of nervous-system pathology. Objective: The aim of this study was to emphasize the potential of 4D ultrasound–based fetal neurobehavioral evaluation (specifically with the Kurjak Antenatal Neurodevelopmental Test, KANET) in detecting abnormal neurobehavior prenatally, and to underline how this method may allow early identification of fetuses at risk for neurodevelopmental impairment. Methods: Review of the concept of fetal neurobehavioral assessment using 4D ultrasound. The KANET test applies 4D ultrasound to observe fetal behavior (movements, facial expressions, general/isolated movements) across gestation, akin to how neonates are neurologically assessed postnatally. By standardizing a scoring system for fetal behaviors relative to gestational age, KANET distinguishes between normal, borderline, and abnormal fetal neurobehavior. Evidence from multicenter studies and clinical/practice settings is considered to assess the feasibility and predictive value of KANET. Results: a) 4D ultrasound makes it possible to observe a wide repertoire of fetal behaviors (limb movements, facial expressions, mouth movements, hand-to-face, general movements), with increasing complexity and organization through gestation - reflecting central nervous system (CNS) maturation. PubMed+2De Gruyter Brill+2; b) Application of KANET in both low-risk and high-risk pregnancies (including growth-restricted and diabetic pregnancies) has shown significant differences in fetal behavior patterns. PubMed+2journaljammr.com+2; c) Postnatal follow-up in some studies found that fetuses with abnormal prenatal KANET scores indeed displayed adverse neurological outcomes - suggesting KANET’s potential as a predictive tool. PubMed+2PubMed+2; d) A recent systematic review (2025) found consistent evidence that behaviors observed via 4D ultrasound (e.g., yawning, hand-to-face, startle, general movements) increase in complexity between approx. 24–34 weeks gestation, coinciding with known neurodevelopmental milestones (e.g., thalamocortical connectivity). PubMed+1; e) However, despite growing evidence for structured fetal behavior as a marker of neural integration, the review cautions that such behaviors cannot yet be equated with consciousness or subjective awareness. PubMed+1.- Conclusion: The advent of 3D/4D ultrasound - and standardized tools like KANET - enables non-invasive prenatal assessment not only of fetal anatomy but also of functional neurodevelopment. Observing and scoring fetal behavior provides a promising avenue for early detection of neurodevelopmental abnormalities. While current evidence supports the use of KANET in clinical practice to identify fetuses at risk for neurodevelopmental impairment, interpretation should remain cautious: observed behaviors likely reflect maturation and neural integration but do not equate to consciousness. Further large-scale, long-term follow-up studies are needed to solidify the predictive validity and clinical utility of prenatal neurobehavioral assessment.

The paper explores the evolving role of Artificial Intelligence (AI) in perinatal medicine and hu-man reproduction, highlighting its potential to transform clinical practices. AI technologies are being utilized to improve diagnostic accuracy, personalize treatment, and enhance patient care, particularly in areas like perinatal ultrasound, fetal heart rate monitoring, and fetal neurology. The Kurjak Antenatal Neurodevelopmental Test (KANET) exemplifies how AI can aid early detection of neurodevelopmental disorders. However, the integration of AI presents challenges such as data quality concerns, algorithmic bias, ethical concerns, and the need for robust regulatory frameworks. The authors argue that while AI offers significant opportunities, its implementation must be carefully managed to avoid over-reliance on technology and ensure equitable healthcare access. The paper concludes that the current state of AI in this field marks not an endpoint but a critical phase of growth and development, necessitating a balanced approach that combines innovation with ethical and practical considerations.